(Corrects to says ‘panel recommends’, not ‘CDC approves’, in headline, paragraph 1)
(Reuters) -The U.S. Centers for Disease Control and Prevention said its advisory committee on Thursday recommended use of Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.
(Reporting by Mrinmay Dey in Bengaluru)
